Which blastocysts should be considered for genetic screening?

Human Reproduction

Volumn 30, Issue 7, 2015, Pages 1743-1744

  Yovich, John L ^a,b   Conceicao, Jason ^a   Hinchliffe, Peter ^a   Keane, Kevin ^a,b  

^a PIVET Medical Centre   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLASTOCYST; COMPARATIVE GENOMIC HYBRIDIZATION; EMBRYO TRANSFER; GENETIC SCREENING; HUMAN; LETTER; LIVE BIRTH; NEXT GENERATION SEQUENCING; NIDATION; PREDICTIVE VALUE; VITRIFICATION DEVICE; ANEUPLOIDY; DNA SEQUENCE; FEMALE; PRENATAL DIAGNOSIS; PROCEDURES;

ANEUPLOIDY; FEMALE; HUMANS; PREIMPLANTATION DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84936797841     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev105     Document Type: Letter

References (4)

1. Fiorentino F, Bono S, Biricik A, Nuccitelli A, Cotroneo E, Cottone G, Kokocinski F, Michel CE, Minasi MG, Greco E. Application of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cycles. Hum Reprod 2014;29:2802-2813.
2. Gardner DK, Schoolcraft WB. In vitro culture of human blastocysts. In: Jansen R, Mortimer D (eds). Toward Reproductive Certainty: Fertility and Genetics Beyond 1999. London, UK: Parthenon Publishing, 1999, 378-388.
3. Kuwayama M, Vajta G, Kato O, Leibo S. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005; 11:300-308.
4. Yovich JL, Conceicao JL, Stanger JD, Hinchliffe PM, Keane KN. Mid-luteal serum progesterone levels govern the implantation rates for frozen embryo transfers conducted under hormone replacement. Reprod Biomed Online 2015 (in press).